NorthWest Biotherapeutics Inc (NWBO)

[Schnauzer1]

All you say may be true. But, the focus of LP on IL-8 as a significant new development as it was newly shown to be highly correlated to survival appears to be overlooked here. But where it gets interesting is when she states that 'we can see the creation of IL-8 even before the conclusion of manufacturing". Was she suggesting that they could use this IL-8 production in the manufacturing process as a predictor of the efficacy of the product? Because the higher the amount of production the higher the correlation to survival. I find this to be interesting. The second proposition that I made was that L and Direct have the same biological form of action. That seems straight forward and apparent as they both are the same D cells but for the timing of the maturation and the uptake of antigens. That being the case (assuming you buy into this for a moment) the question is can NWBO look at the batch of L product at the end of manufacturing and determine with more accuracy the individuals who will have greater success than the rest? That would, of course, be quite significant.